ResMedRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
ResMed (RMD) reported revenue of $1.46B in Q2 2026, with Sleep & Respiratory its largest revenue segment at 88%.
ResMedResMed designs cloud-connected sleep and breathing devices, masks, and digital health software. It sells in more than 140 countries from San Diego and had more than 35 million patients on cloud-connected AirView devices as of fiscal 2026.
ResMed (RMD) is a Health Care Equipment company. ResMed designs cloud-connected sleep and breathing devices, masks, and digital health software. It sells in more than 140 countries from San Diego and had more than 35 million patients on cloud-connected AirView devices as of fiscal 2026. It was founded in 1989, is headquartered in San Diego, California and employs about 11,370 people.
As of 2025-Q4, ResMed's revenue breaks down across Sleep & Respiratory (88%), Residential Care Software (12%). See the revenue-by-segment chart for the full mix.
Track ResMed's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 26, 2026.
Sterling groups ResMed in the Healthcare sector, alongside Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW) and GE HealthCare (GEHC).
If you are researching ResMed, also look at Abbott Laboratories (ABT), Baxter International (BAX) and Becton Dickinson (BDX). You can compare all of them side by side or browse the full Healthcare sector on Sterling.
Q3 2016-Q2 2026
Q3 2016-Q2 2026